RE:RE:RE:RE:Esbriet’s Efficacy in Severe IPF Seen to Diminish 6-12 MonthBig Pharma would not short a potential target. They
would hire persons unknown to talk the Stock down while at
the same time nibbling at 9.9999% or slightly more than 70 million shares.
Then a takeover at 5.00 after the next FDA yes is a more likely scenario
The shorting started at over 3.00 a little late for the conscripts but
why they have not been covering since the Thomvest back up
funding is the big mystery. Within 50 hours we will have the Q3 news and perhaps
another piece of the where do we go from here puzzle.